Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
43,568,892
-
Share change
-
+1,723,756
-
Total reported value
-
$1,357,193,862
-
Put/Call ratio
-
233%
-
Price per share
-
$31.15
-
Number of holders
-
161
-
Value change
-
+$18,538,136
-
Number of buys
-
80
-
Number of sells
-
96
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2018
As of 31 Mar 2018,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,568,892 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Consonance Capital Management LP, HealthCor Management, L.P., PointState Capital LP, PRICE T ROWE ASSOCIATES INC /MD/, venBio Select Advisor LLC, Partner Fund Management, L.P., MACQUARIE GROUP LTD, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
161
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.